Bayer is trying to make one science company work at three speeds: the long clock of drug discovery, the seasonal rhythm of farming and the everyday urgency of self-care. Its turnaround will depend on whether that range becomes an advantage rather than a burden.
Hexagon Bio is a Menlo Park biotech that mines the genomes of fungi and other microbes to discover new medicines. Its platform pairs machine learning, genomics, and synthetic biology to read DNA sequences, predict the small molecules they encode, and connect those molecules to the human proteins they act on - skipping the random trial-and-error that has long defined natural-product drug discovery. The company is focused on novel cytotoxic payloads for antibody-drug conjugates (ADCs) in oncology, and in late 2025 extended its approach to agriculture through a joint venture with Corteva.
Pyka builds large autonomous, all-electric aircraft for crop protection and cargo logistics. Headquartered in Alameda, California, the company designs its own airframes, batteries, flight computers, and autonomy stack, and flies them commercially across four continents for customers in agriculture, freight, and defense.